Viewing Study NCT01227018


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-07-06 @ 4:20 AM
Study NCT ID: NCT01227018
Status: TERMINATED
Last Update Posted: 2014-07-23
First Post: 2010-10-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Pancreas View
None Recurrent Pancreatic Cancer View
None Stage IV Pancreatic Cancer View
Keywords: